EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Rethinking endpoints, subgroup analyses, and time-varying treatment in AST-120 CKD research

Menglong Li

Journal of the Formosan Medical Association · 2026-08

DOI: 10.1016/j.jfma.2026.08.025 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the Formosan Medical Association, 2026-08. Verfasst von Menglong Li. Beteiligte Einrichtung: Evidence-based Medicine Center, Beijing Luhe Hospital, Capital Medical University, No. 82, Xinhua South Road, Tongzhou District, Beijing, 101149, Chi…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Evidence-based Medicine Center, Beijing Luhe Hospital, Capital Medical University, No. 82, Xinhua South Road, Tongzhou District, Beijing, 101149, China. Electronic address: limenglong_ph@163.com.

Zitieren

APA

Li, M. (2026). Rethinking endpoints, subgroup analyses, and time-varying treatment in AST-120 CKD research. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2026.08.025

Vancouver

Li M. Rethinking endpoints, subgroup analyses, and time-varying treatment in AST-120 CKD research. Journal of the Formosan Medical Association. 2026. doi:10.1016/j.jfma.2026.08.025

BibTeX
@article{Li2026,
  author = {Li, Menglong},
  title = {Rethinking endpoints, subgroup analyses, and time-varying treatment in AST-120 CKD research},
  journal = {Journal of the Formosan Medical Association},
  year = {2026},
  doi = {10.1016/j.jfma.2026.08.025}
}
Kostenlos starten →